Ciclodin Adverse Reactions

Those indicating need for medical attention: Incidence less frequent: Phototoxicity (blisters; sensation of skin burning; skin itching, rash, or redness; swelling).
Incidence rare: Arthralgia (joint pain); CNS stimulation (acute psychosis; agitation; confusion; hallucinations; tremors); cardiovascular reactions such as palpitation (fast or irregular heartbeat); vasodilation (dizziness; faintness; feeling of warmth or heat; flushing or redness of skin especially on face and neck; headache; lightheadedness; sweating; weakness); or tachycardia (fainting; fast, pounding, or irregular heartbeat or pulse); hematuria (blood in urine); hepatoxicity (dark or amber urine; loss of appetite; pale stools; stomach pain; unusual tiredness or weakness; yellow eyes or skin); hypersensitivity reactions (skin rash, itching, or redness; shortness of breath; swelling of face or neck; vasculitis); interstitial nephritis (bloody or cloudy urine; fever; skin rash; swelling of feet or lower legs).
Those indicating need for medical attention only if they continue or are bothersome: Incidence more frequent: CNS toxicity (dizziness or lightheadedness; headache; nervousness; drowsiness; insomnia); gastrointestinal reactions (abdominal or stomach pain or discomfort, mild; diarrhea, mild; nausea or vomiting).
Incidence less frequent or rare: Back pain; change in sense of taste; dream, abnormal; dysuria (difficulty in urination); headache; moniliasis, oral (sore mouth or tongue; white patches in mouth and/or tongue); moniliasis, vaginal (vaginal yeast infection); myalgia (muscle pain); photosensitivity (increased sensitivity of skin to sunlight); vision, abnormal.
Note: Some patients note a reduced incidence of nausea and taste perversion if the dose is administered in the evening. Photosensitivity reactions generally appear within a few days of the start of fluoroquinolone treatment but can occur up to 3 weeks after discontinuation. The reactions usually subside within 1 month of discontinuation.
Those indicating possible phototoxicity, pseudomembranous colitis, or tendinitis or tendon rupture and the need for medical attention if they occur after medication is discontinued: Abdominal or stomach cramps and pain, severe; abdominal tenderness; blisters; diarrhea, watery and severe, which may also be bloody; fever; pain in calves, radiating to heels; sensation of skin burning; skin rash, itching, or redness; swelling of calves or lower legs.